AVROBIO, Inc. Common Stock

AVRO

...

AVRO: Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease.

Show AVRO Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of AVRO by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AVRO's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on AVRO's company Twitter account

WallStreetBets

Number of mentions of AVRO in WallStreetBets Daily Discussion

AVRO News

Recent insights relating to AVRO

CNBC Recommendations

Recent picks made for AVRO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AVRO

Corporate Flights

Flights by private jets registered to AVRO